In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy
Until the recent development of disease-modifying therapeutics, spinal muscular atrophy (SMA) was considered a devastating neuromuscular disease with a poor prognosis for most affected individuals. Symptoms generally present during early childhood and manifest as muscle weakness and progressive para...
Main Authors: | Kristine S. Ojala, Emily J. Reedich, Christine J. DiDonato, Stephen D. Meriney |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/11/2/194 |
Similar Items
-
Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders
by: Sibylle Jablonka, et al.
Published: (2022-01-01) -
ERK and ROCK functionally interact in a signaling network that is compensationally upregulated in Spinal Muscular Atrophy
by: Niko Hensel, et al.
Published: (2017-12-01) -
Molecular and Epidemiological Characterization of SMN Genes in Cuban Patients with Spinal Muscular Atrophy
by: Fabián Lombillo-Alfonso, et al.
Published: (2020-01-01) -
Establishing a standardized therapeutic testing protocol for spinal muscular atrophy
by: Li-Kai Tsai, et al.
Published: (2006-11-01) -
Innovating spinal muscular atrophy models in the therapeutic era
by: Ilaria Signoria, et al.
Published: (2023-09-01)